Fundamental Analysis:
Ticker
HBP:CA
Current Price
$2.4 -14.29%
Market Cap
$178.0M
Price Target
Refer to Report
Volume
37.4K
52wk Range
$0.5 - $5.4
Overview
Helix BioPharma Corp is a Canada-based clinical-stage biopharmaceutical company focused on cancer drug development. It develops therapies in the field of immuno-oncology based on its proprietary technology mainly in the areas of cancer prevention and treatment. The company has Tumor Defense Breakers (L-DOS47), and Tumor Attackers (CAR-T) product candidates in the pipeline.